Type 2 severe asthma: pathophysiology and treatment with biologics.

Corrado PelaiaJames MelhornTimothy Sc HinksSimon CouillardAlessandro VatrellaGirolamo PelaiaIan D Pavord

Published in: Expert review of respiratory medicine (2024)

The main result of the recent advances in the field of anti-asthma biologic therapies is the implementation of a personalized medicine approach, aimed to achieve clinical remission of severe asthma. Today this accomplishment is made possible by the right choice of the most beneficial biologic drug for the pathologic traits characterizing each patient, including type 2 severe asthma and its comorbidities.

Keyphrases

rheumatoid arthritis
primary care
chronic obstructive pulmonary disease
healthcare
disease activity
case report
neoadjuvant chemotherapy
genome wide
gene expression
squamous cell carcinoma
combination therapy
radiation therapy
drug induced
allergic rhinitis
adverse drug
decision making